OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Your search returned 8 results.    Search:   Expanded Search
Genes match for AY665468   Similar terms to AY665468

   RASSF8   (C12orf2;DKFZp434O0227;FLJ11542;HOJ1;HoJ-1;)


|<<     <<      >>     >>|   total pages:0
SKU   Category   Vector   Tag   Description   $ Price   Availability  
  SC128045     Human Clone pCMV6-XL4 No Tags (untagged)-ORIGENE UNIQUE VARIANT 1 of Human clone B4-E11 carcinoma associated protein HOJ-1 (10ug) 850 2-3 weeks
SKU   Category   Vector   Description   $ Price   Availability  
  TR309925     Human shRNA pRS RASSF8 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector 650 7-9 Days
  TL309925     Human shRNA pGFP-C-shLenti RASSF8 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 7-9 Days
  TF309925     Human shRNA pRFP-C-RS RASSF8 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector 650 7-9 Days
  TG309925     Human shRNA pGFP-V-RS RASSF8 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector 650 7-9 Days
  SR307702     Human siRNA RASSF8 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each 390 2 weeks
  TL504534     Mouse shRNA pGFP-C-shLenti RASSF8 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 7-9 Days
SKU   Category   Description   $ Price   Availability  
  KN206104     knockout RASSF8 - gene knockout kit via CRISPR 1200 4 wks
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title